Supreme Court Report

Supreme Court of the United States · Official docket →

Pfizer Inc., et al. v. Superior Court of California, County of Los Angeles, et al.

Paid petition · Court of Appeal of California, Second Appellate District, No. B296917 · judgment May 13, 2019


Certiorari denied · November 25, 2019
Pre-decision estimate: 7% cert probability (95% interval 5%–10%)

Before the decision, about 1.7× the 4.1% base rate. The model weighted this up for a circuit split argued in the petition, a dissent in the court below (flagged in the petition), and a business petitioner.

Question presented

This Petition concerns the California state courts’ undisputed lack of personal jurisdiction over products liability claims filed against Petitioners by more than 3,600 non-resident Plaintiffs. This Court’s decision in Bristol-Myers Squibb v. Superior Court, 137 S. Ct. 1773 (2017), held that due process forbids the California courts from exercising personal jurisdiction over such claims. Yet, rather than applying Bristol-Myers, the California courts forged a path around it, ruling that Petitioners had forfeited their admittedly meritorious defense. Purporting to apply federal law, the California courts crafted a forfeiture rule contrary to this Court’s precedents and all controlling law in the Courts of Appeals: that Petitioners forfeited their right to contest personal jurisdiction, despite having timely raised the challenge, because they did not file a personal jurisdiction motion simultaneous with their attempts to establish subject matter jurisdiction in federal court. The question presented is whether, under federal law, a defendant’s efforts to establish federal subject matter jurisdiction can result in forfeiture of an otherwise fully preserved challenge to personal jurisdiction.

Counsel of record

For petitioner
Michael Hugh McGinley
Dechert LLP

For respondent
Jules Burton LeBlanc IV
Baron & Budd, P.C.

Case

Conference history
Distributed for 1 conference

Amicus briefs
1 cert-stage

Proceedings

  1. Nov 25 2019
    Petition DENIED.
  2. Nov 06 2019
    DISTRIBUTED for Conference of 11/22/2019.
  3. Nov 05 2019
    Reply of petitioners Pfizer, Inc., et al. filed.
  4. Oct 23 2019
    Brief of respondents County of Los Angeles, et al. in opposition filed.
  5. Oct 03 2019
    Brief amici curiae of The American Tort Reform Association, The National Association of Manufacturers, The Pharmaceutical Research and Manufacturers of America and the Product Liability Advisory Council filed.
  6. Sep 25 2019
    Motion to extend the time to file a response from October 3, 2019 to November 4, 2019, submitted to The Clerk.
  7. Sep 25 2019
    Motion to extend the time to file a response is granted and the time is extended to and including November 4, 2019.
  8. Aug 28 2019
    Petition for a writ of certiorari filed. (Response due October 3, 2019)